- Home
- BRKR
BRKR
Bruker Corporation
as 04-18-2025 1:32pm EST
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, applied markets, pharmaceutical, and biotechnology industries. The company operates in segments, namely, Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Supercon Technologies (BEST). The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from United States.
| Founded: | 1960 | Country: | United States |
| Employees: | N/A | City: | BILLERICA |
| Market Cap: | 5.8B | IPO Year: | 2000 |
| Target Price: | $63.40 | AVG Volume (30 days): | 2.7M |
| Analyst Decision: | Buy | Number of Analysts: | 12 |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | 0.76 | EPS Growth: | -73.83 |
| 52 Week Low/High: | $34.10 - $84.90 | Next Earning Date: | 05-07-2025 |
| Revenue: | $3,366,400,000 | Revenue Growth: | 13.56% |
| Revenue Growth (this year): | 5.66% | Revenue Growth (next year): | 5.99% |
Stock Insider Trading Activity of Bruker Corporation (BRKR)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Bures Thomas | BRKR | Chief Accounting Officer | Mar 10 '25 | Buy | $47.40 | 500 | $23,697.50 | 3,472 | |
| LAUKIEN FRANK H | BRKR | PRESIDENT & CEO | Feb 18 '25 | Buy | $50.99 | 20,000 | $1,018,329.76 | 38,452,626 |
Latest Bruker Corporation News
BRKR Breaking Stock News: Dive into BRKR Ticker-Specific Updates for Smart Investing
Insider Monkey
a day ago
Bruker Corporation (BRKR): Among Mid-Cap Stocks Insiders Were Buying in Q1 2025
Medical Device Network
2 days ago
Bruker to invest in German company RECIPE
Business Wire
2 days ago
Bruker Introduces nVista 2P Miniature Microscope
MT Newswires
3 days ago
Bruker Acquires Majority Stake in RECIPE Chemicals
Business Wire
3 days ago
Bruker Announces Majority Acquisition of RECIPE, a Leading Provider of Mass Spectrometry-based Diagnostic Assay Kits for Therapeutic Drug Monitoring
Argus Research
3 days ago
BRKR: Raising target price to $40.00
MT Newswires
5 days ago
BofA Securities Lowers Bruker Price Target to $61 From $76
Zacks
5 days ago
Bruker Stock May Benefit Following Its Investment in Ridom GmbH
Compare BRKR vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "BRKR Bruker Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.